A Phase II Clinical Trial of High Dose Vitamin D3 Supplementation in Combination With FOLFOX + Bevacizumab in the 1st Line Treatment of Metastatic Colorectal Cancer.
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Bevacizumab; Colecalciferol; Fluorouracil; Folinic acid; Oxaliplatin
- Indications Colorectal cancer
- Focus Therapeutic Use
- 21 Jul 2014 Biomarkers information updated
- 05 Sep 2012 Planned end date changed from 1 Oct 2012 to 1 Sep 2012 as reported by ClinicalTrials.gov.
- 09 Aug 2012 Planned End Date changed from 1 Jul 2012 to 1 Oct 2012 as reported by ClinicalTrials.gov.